• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咖啡酸通过 FOXO1/FIS 通路抑制三阴性乳腺癌细胞的致瘤性。

Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway.

机构信息

College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, 4, Dongqing Road, Huaxi District, Guiyang 550025, China.

Department of Medicinal Chemistry, College of Pharmaceutical Sciences of Capital Medical University, 10, Xitoutiao, Right Anmen West, Fengtai District, Beijing 100069, China.

出版信息

Biomed Pharmacother. 2024 Sep;178:117158. doi: 10.1016/j.biopha.2024.117158. Epub 2024 Jul 22.

DOI:10.1016/j.biopha.2024.117158
PMID:39042963
Abstract

Triple-negative breast cancer (TNBC) still one of the most challenging sub-type in breast cancer clinical. Caffeic acid (CA) derived from effective components of traditional Chinese herbal medicine has been show potential against TNBCs. Our research has found that CA can inhibit the proliferation of TNBC cells while also suppressing the size of cancer stem cell spheres. Additionally, it reduces reactive oxygen species (ROS) levels and disruption of mitochondrial membrane potential. Simultaneously, CA influences the stemness of TNBC cells by reducing the expression of the stem cell marker protein CD44. Furthermore, we have observed that CA can modulate the FOXO1/FIS signaling pathway, disrupting mitochondrial function, inducing mitochondrial autophagy, and exerting anti-tumor activity. Additionally, changes in the immune microenvironment were detected using a mass cytometer, we found that CA can induce M1 polarization of macrophages, enhancing anti-tumor immune responses to exert anti-tumor activity. In summary, CA can be considered as a lead compound for further research in targeting TNBC.

摘要

三阴性乳腺癌(TNBC)仍然是乳腺癌临床中最具挑战性的亚型之一。咖啡酸(CA)来源于中草药的有效成分,已被证明对 TNBC 具有潜在的作用。我们的研究发现,CA 可以抑制 TNBC 细胞的增殖,同时抑制肿瘤干细胞球体的大小。此外,它还降低了活性氧(ROS)水平并破坏了线粒体膜电位。同时,CA 通过降低干细胞标志物蛋白 CD44 的表达来影响 TNBC 细胞的干性。此外,我们观察到 CA 可以调节 FOXO1/FIS 信号通路,破坏线粒体功能,诱导线粒体自噬,并发挥抗肿瘤活性。此外,使用质谱细胞仪检测到免疫微环境的变化,我们发现 CA 可以诱导巨噬细胞的 M1 极化,增强抗肿瘤免疫反应,发挥抗肿瘤活性。总之,CA 可以被认为是针对 TNBC 的进一步研究的先导化合物。

相似文献

1
Caffeic acid inhibits the tumorigenicity of triple-negative breast cancer cells through the FOXO1/FIS pathway.咖啡酸通过 FOXO1/FIS 通路抑制三阴性乳腺癌细胞的致瘤性。
Biomed Pharmacother. 2024 Sep;178:117158. doi: 10.1016/j.biopha.2024.117158. Epub 2024 Jul 22.
2
The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair.自噬抑制剂氯喹通过诱导线粒体损伤和损害DNA断裂修复来靶向三阴性乳腺癌中的癌症干细胞。
Cancer Lett. 2016 Jul 1;376(2):249-58. doi: 10.1016/j.canlet.2016.04.002. Epub 2016 Apr 6.
3
Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.蒲公英提取物通过抑制 IL-10/STAT3/PD-L1 信号通路抑制肿瘤相关巨噬细胞微环境中三阴性乳腺癌细胞的恶性表型。
J Ethnopharmacol. 2021 Jun 28;274:113978. doi: 10.1016/j.jep.2021.113978. Epub 2021 Mar 11.
4
MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.MCT-1/miR-34a/IL-6/IL-6R 信号轴促进三阴性乳腺癌中的 EMT 进展、癌症干性和 M2 巨噬细胞极化。
Mol Cancer. 2019 Mar 18;18(1):42. doi: 10.1186/s12943-019-0988-0.
5
Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.人参皂苷 Rk1 诱导 MDA-MB-231 三阴性乳腺癌细胞周期停滞和凋亡。
Toxicology. 2019 Apr 15;418:22-31. doi: 10.1016/j.tox.2019.02.010. Epub 2019 Feb 21.
6
Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.发现一种天然小分子化合物,通过抑制三阴性乳腺癌中的 TGFβ/BMP 信号通路来抑制肿瘤 EMT、干性和转移。
J Exp Clin Cancer Res. 2019 Mar 21;38(1):134. doi: 10.1186/s13046-019-1130-2.
7
Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.云南茜草素 C,一种从云南茜草中分离得到的天然萘二酚二聚体,通过诱导 ROS 介导的凋亡和自噬性细胞死亡来抑制三阴性乳腺癌细胞的增殖和转移。
J Ethnopharmacol. 2021 Sep 15;277:114184. doi: 10.1016/j.jep.2021.114184. Epub 2021 May 4.
8
Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.鉴定与三阴性乳腺癌中 BET 抑制相关的干性相关基因谱。
Cell Oncol (Dordr). 2020 Jun;43(3):431-444. doi: 10.1007/s13402-020-00497-6. Epub 2020 Mar 12.
9
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer.维生素D通过抑制核因子κB信号传导并降低三阴性乳腺癌中NLRP3的表达来抑制CD133+/CD44+癌干细胞的干性。
Cancer Chemother Pharmacol. 2024 Jul;94(1):67-78. doi: 10.1007/s00280-024-04660-w. Epub 2024 Mar 8.
10
Ursolic acid inhibits the proliferation of triple‑negative breast cancer stem‑like cells through NRF2‑mediated ferroptosis.熊果酸通过 NRF2 介导的铁死亡抑制三阴性乳腺癌干细胞样细胞的增殖。
Oncol Rep. 2024 Jul;52(1). doi: 10.3892/or.2024.8753. Epub 2024 Jun 7.

引用本文的文献

1
Anticancer Activity of Ethanolic Extract of in Breast Cancer Lines MCF-7 and MDA-MB-231.[提取物名称]乙醇提取物对乳腺癌细胞系MCF-7和MDA-MB-231的抗癌活性
Int J Mol Sci. 2025 Aug 21;26(16):8111. doi: 10.3390/ijms26168111.
2
Progress of Traditional Chinese Medicine in Regulating Immune Cell in the Tumor Microenvironment of Triple-Negative Breast Cancer.中医药调控三阴性乳腺癌肿瘤微环境中免疫细胞的研究进展
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251349824. doi: 10.1177/15347354251349824. Epub 2025 Jun 20.
3
Parishin B blocking TRIB3-AKT1 interaction inhibits breast cancer lung metastasis.
Parishin B阻断TRIB3-AKT1相互作用可抑制乳腺癌肺转移。
Front Pharmacol. 2025 Jan 15;15:1517708. doi: 10.3389/fphar.2024.1517708. eCollection 2024.